T2D diagnosed within last 6 years may be able to achieve remission if substantial weight loss is achieved.

By Sheri R. Colberg: Exploring the Benefits of Spontaneous Physical Activity

You’ve probably heard about the recent reports revealing just how dangerous it is to be sedentary. Simply sitting for too long at one time is now a recognized health hazard that everyone should be aware of. But if you suffer from diabetes or prediabetes, a sedentary lifestyle is particularly dangerous. Getting regular exercise and movement is one of the most important things you can do to keep your blood glucose under control, maintain a healthy body weight, and reduce your risk of developing complications related to diabetes.

What percentage of time do you recommend a sulfonylurea because that is what the patient can afford? Follow the link to see how you compare to your colleagues.

A 59-year-old patient who was diagnosed with type 2 diabetes five years ago presents to your clinic for an appointment. He has a history of hypertension and dyslipidemia, both currently well-controlled with medication. He has been taking metformin and a DPP-4 inhibitor. He tells you he is concerned about a sore on his foot that is taking a long time to heal. At today’s visit, his office A1C is 8.8%. After discussing his options, you decide to add basal insulin analogue detemir to his regimen. Compared to insulin NPH, what would you expect him to experience while taking detemir? A. Less weight gain B. More hypoglycemia C. More weight gain D. No weight gain or hypoglycemia difference Follow the link for the answer.

Ken Fujioka is director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic. His time is divided equally between clinical research and clinical practice. Research includes diets, medications, bariatric surgery, medical devices, web based weight loss programs, and outcomes in obesity treatment.

In this Exclusive Interview transcript Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA, about his work in both clinical practice and clinical research on treating obesity and how weight loss affects type 2 diabetes.

In this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about treating obesity and the role of weight loss in managing type 2 diabetes.

In part 1 of this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the various weight loss conditions a patient may experience and the medications that can help.

In part 2 of this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the practitioner coverage available to the patients of his practice.

In part 3 of this Exclusive Interview, Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about the most effective exercises and best method for patients who want to monitor their weight loss.